The CAR T-cell therapy market for acute lymphoblastic leukemia is poised for substantial growth, driven by the anticipated launch of therapies such as OBECABTAGENE AUTOLEUCEL (OBE-CEL), UCART22
Diabetic Kidney Disease Market Is Anticipated To Grow At A CAGR Of ~6.5% By 2034, Analyzes Delveinsight | Boehringer Ingelheim, Daiichi Sankyo, Prokid... menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.
Gene Therapies in Ophthalmology Market to Register Immense Growth at a CAGR of 57.8% by 2034 lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.
According to DelveInsight’s analysis, the growth of the gene therapies market in ophthalmology is expected to be mainly driven by the increasing prevalence of eye disease, rise in awareness and access to treatment, increased adoption of enhanced genetic testing and robust pipeline activity for eye disease in the 7MM. LAS VEGAS, April 4, 2024 /PRNewswire/ […]
/PRNewswire/ DelveInsight s Gene Therapies in Ophthalmology Market Insights report includes a comprehensive understanding of current treatment practices,.